Introduction to Veri-T: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD-TDP.

Peter A. Ljubenkov, Adam M. Staffaroni, Julio C. Rojas, Lawren VandeVrede, Mary Koestler, Tayler A Sulse, Julia Moreton, Sheena Horiki, Hilary W. Heuer, Ian Grant, David J. Irwin, Bradley F. Boeve, Howard J. Rosen, David S. Knopman, Robert Bowser, Murray Grossman, Irfan Qureshi, Adam L. Boxer. Introduction to Veri-T: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD-TDP. Alzheimer's & Dementia. 2022 Dec 20; 18(S10).

2022
https://researcherprofiles.org/profile/368859522

Peter A. Ljubenkov, Adam M. Staffaroni, Julio C. Rojas, Lawren VandeVrede, Mary Koestler, Tayler A Sulse, Julia Moreton, Sheena Horiki, Hilary W. Heuer, Ian Grant, David J. Irwin, Bradley F. Boeve, Howard J. Rosen, David S. Knopman, Robert Bowser, Murray Grossman, Irfan Qureshi, Adam L. Boxer